As we age, we may find that the soft, full hair we have taken for granted in our younger days becomes thinner and more brittle. Hair grows less than half an inch every month, so the hair on your head has experienced years of damage and sun exposure from the elements. It also is affected by naturally diminishing hormonal levels which play a role in hair growth, texture, and greying. Androgenetic alopecia, also known as male baldness, is the most common type of hair loss in both men and women.
PTD-DBM which is short for Protein transduction domain (PTD)-Dvl-binding motif (DBM).
PTD-DBM is a hair follicle regeneration treatment. More specifically, it is a peptide-based topical scalp treatment which inhibits the follicle shrinking action of the body’s hormones and enzymes effectively rescuing the follicle at a stem cell level. Treatment with PTD-DBM both prevents hair loss and promotes the growth of new hair follicles.
Professor Choi Kang-yeol of Yonsei University in South Korea and a team of researchers discovered a peptide responsible for hair loss in the condition known as androgenetic alopecia. This peptide controls hair growth and the researcher developed a new substance that promotes hair regeneration by controlling the function of the protein. This peptide is called PTD-DBM.
After seeing the success with PTD-DBM, additional research was gathered to make the ideal treatment for hair regrowth a three-prong approach.
How the three fold protocol works. The microneedling induces the generation of follicles, the PTD-DBM stimulates hair growth and the valproic acid reduces the rate in which the hair dies and falls out. When these three processes are combined hair grows back quickly.